Synthon (Netherlands) holds 18 active US FDA Type II Drug Master Files and 6 inactive and has DMF or CEP filings on record for 30 active ingredients. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Synthon: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/synthon

Overview

Synthon is a pharmaceutical company headquartered in Nijmegen, Netherlands.

Core services & business areas

Pharmaceutical DevelopmentContract ManufacturingRegulatory AffairsQuality Assurance

Active ingredients with DMF or CEP filings

Substances for which Synthon holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Synthon holds 18 active (24 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • RUXOLITINIB PHOSPHATEActive2026-09-28
  • DABRAFENIB MESYLATEActive2026-09-14
  • NUSINERSEN SODIUMActive2026-03-17
  • SIPONIMOD ADIPIC ACIDActive2025-09-25
  • VISMODEGIBActive2025-07-17
  • IXAZOMIB CITRATEActive2025-01-30
  • TIVOZANIB HYDROCHLORIDE MONOHYDRATEActive2024-09-10
  • OZANIMOD HYDROCHLORIDEActive2023-11-23
  • AXITINIBActive2023-02-02
  • ENZALUTAMIDEActive2021-10-29
  • PALBOCICLIBActive2020-04-14
  • LENALIDOMIDEActive2020-03-27
  • SUGAMMADEX OCTASODIUMActive2019-07-10
  • VALSARTAN DISODIUMActive2019-03-07
  • MIRABEGRONActive2018-02-02
  • POMALIDOMIDEActive2016-08-02
  • GEFITINIBActive2015-11-17
  • TAMSULOSIN HYDROCHLORIDEActive2006-12-21
  • LEVOCETIRIZINE DIHYDROCHLORIDEInactive2011-01-19
  • ZOLPIDEM TARTRATEInactive2009-03-27
  • ARIPIPRAZOLEInactive2006-08-11
  • ANASTROLZOLEInactive2006-02-27
  • AMLODIPINE BESYLATE MONOHYDRATEInactive2005-10-11
  • SIMVASTATINInactive2005-05-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Synthon in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Synthon?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.